Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 809 results for "eli lilly"

Eli Lilly and Co. Expected to Earn Q3 2016 Earnings of $0.92 Per Share (LLY)
SleekMoney

Eli Lilly and Co. Expected to Earn Q3 2016 Earnings of $0.92 P...

Eli Lilly and Co. (NYSE:LLY) Equities researchers at Leerink Swann upped their Q3 2016 earnings per share (EPS) estimates for shares of Eli Lilly and in a report issued on Tuesday. Leerink Swann analyst S. Fernandez now anticipates that the ... SleekMoney, 6 hours ago
[x]  

349 images for eli lilly

Ticker Report, 2 hours ago
American Banking News, 16 hours ago
CNBC, 4 days ago
irishtimes.com, 4 days ago
BioSpace, 2 days ago
Yahoo! Singapore, 3 days ago
Bidness Etc, 3 days ago
Xconomy, 3 days ago
businessinsider.com, 3 days ago
Reuters, 2 days ago
Pharmafile

Eli Lilly appoints David A Ricks as new president & CEO effective from January 2017

Eli Lilly and Company, a global healthcare leader, announced that John C Lechleiter, Ph.D., chairman, president and chief executive officer, will retire as president and CEO and from the company effective December 31, 2016. Lechleiter will continue ...
 PharmaBiz1 day ago Eli Lilly and Company (NYSE:LLY) Has Been Assigned An ABR Of 1.92  Markets Daily22 hours ago Eli Lilly : U.S. FDA expands indication for type 2 diabetes treatment Synjardy┬« empagliflozin/metformin hydrochloride to include treatment-naive adults  4 Traders1 day ago ACRUX : Axiron Net Sales, quarter to June 2016  4 Traders2 days ago
[x]  

BRIEF-Eli Lilly says got civil investigative demand from U.S. Attorneys office for southern district of New York

July 28 Eli Lilly * Received a civil investigative demand from the u.s. attorney's office for southern district of New York - Filing * Civil investigative demand related to documents and information relating to our contracts with, services ...
 Reuters UK1 day ago Eli Lilly Faces Probe Over Contracts With Pharmacy Benefit Managers  BioSpace1 day ago U.S. probes contracts between Eli Lilly and PBMs  Sharenet1 day ago Eli Lilly says authorities seek documents on PBM contracts  Sharenet1 day ago
[x]  
Bloomberg

Lilly Posts Higher Drug Sales, Plans to Increase Dividend

Eli Lilly & Co. posted second-quarter earnings that matched analysts estimates as revenue surged, led by growing U.S. sales of the company's top drugs such as the erectile dysfunction pill Cialis and the diabetes treatment Humalog. Profit excluding ...
 Bloomberg3 days ago Lilly profit matches estimates as U.S. drug sales grow  LifeHealthPro3 days ago Merck's Profit Beats Estimates on Diabetes Drug Sales  Bloomberg23 hours ago
Nasdaq

BRIEF-Eli Lilly reports quarterly earnings of $0.71 per share

July 26 Eli Lilly And Co * Q2 earnings per share $0.71 * Q2 non-gaap earnings per share $0.86 * * Q2 earnings per share view $0.86 -- Thomson Reuters I/B/E/S * For Q2 of 2016, alimta generated revenues of $607.1 million, a ...
 Reuters UK4 days ago Merck (MRK) Updates Outlook Following Q2 Earnings Beat  Yahoo! Singapore1 day ago
[x]  
Bloomberg

Lilly Turns From One Company Veteran to Another for New CEO

Over the last eight years, Eli Lilly & Co. relied on a three-decade company veteran to steer it through declining sales and a struggling product pipeline. Now it's turned to another long-time executive for its next chapter. On Wednesday, the ...
 Bloomberg2 days ago
FOXBusiness.com

Lilly 2Q Profit, Sales Jump on New Drugs

Eli Lilly and Co reported a 24.5 percent jump in quarterly profit, driven by demand for its newer treatments for diabetes and cancer. Continue Reading Below The 140-year-old U.S. drugmaker said its net income rose to $747.7 million, or 71 ...
 FOXBusiness.com4 days ago Eli Lilly posts higher Q2 profit, sales on stronger demand for new drugs  FirstWord Pharma4 days ago Lilly sales beat estimates, helped by newer drugs  Reuters4 days ago Lilly quarterly profit, sales jump on demand for new drugs  Sharenet4 days ago
[x]  

Technical Alert: Eli Lilly Unchanged After Wild Ride Following Q2 Report

$83.38 - Intraday high as of 1:43 PM $83.35 - January 27 high $83.20 - January 25 high $83.16 - January 22 high $81.98 - Current price/Monday close $81.63 - Intraday low as of 1:43 PM $81.00 - Monday low If content like this is useful to ...
 Benzinga.com3 days ago
Irish Times

New drugs deliver for Eli Lilly

Cancer and diabetes therapies drive 24.5% growth in profit after tax Eli Lilly reported better-than-expected quarterly sales, driven by demand for its newer treatments for diabetes and cancer. Revenue rose 8.6 per cent to $5.4 billion in the second ...
 Irish Times4 days ago Lilly beats Street 2Q forecasts  NewsFlow244 days ago New diabetes and cancer drugs deliver for Eli Lilly  Irish Times4 days ago

Lilly Q2 top line up 9%; EPS up 27%; non-GAAP EPS down 4%

Eli Lilly (NYSE: LLY ) Q2 Results ($M): Total Revenues: 5,404.8 (+8.6%); Animal Health: 859.8 (+2.3%). Net Income: 747.7 (+24.5%); Non-GAAP Net Income: 908.8 (-4.8%); EPS: 0.71 (+26.8%); Non-GAAP EPS: 0.86 (-4.4%). Key Product Sales: Humalog: ...
 Seeking Alpha4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - eli lilly
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less